Market Scope Market Research Future (MRFR)’s newly released study reveals that the Urinary Tract Infection Market will expand at a rate of 3.5% from 2022 to 2030. The market valuation by the end of the analysis period will be around USD 11.3 billion, adds the extensive report. Top Firms Allergan, Eli Lily, Company, GlaxoSmithKline plc, Cipla Inc., Pfizer Inc., Novo Nordisk A/S, Bayer AG,...